摘要
Acute coronary syndrome (ACS) is one of the most dangerous types of coronary heart disease (CHD) and contributes to significant mortality and morbidity worldwide. Outcomes in these patients remain a challenge despite improvements in diagnosis and treatment. Risk stratification continues to be problematic and the identification of novel predictors is crucial for improved outcomes. As such, there is a strong need for the development of novel analytical methods as well as the characterization of better predictive and prognostic biomarkers to enable more personalized treatment. Metabolite profile analysis may greatly assist in interpreting altered pathway dynamics, especially when combined with other 'omits' technologies such as transcriptomics and proteomics. In this review, we describe ACS pathophysiology and recent advances in the role of metabolomics in the diagnosis and the molecular pathogenesis of ACS. We briefly describe key technologies used in metabolomics research and statistical approaches for data reduction and pathway analysis and discuss their application to CHD.
学科与关键词
- Metabolomics applications in coronary artery disease personalized medicineAmin, Arwa M.*ELSEVIER ACADEMIC PRESS INC,525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA, 2021.被引 10
- Comprehensive Metabolomics Identified the Prominent Role of Glycerophospholipid Metabolism in Coronary Artery Disease ProgressionChen, Hui; Wang, Zixian; Qin, Min; Zhang, Bin; Lin, Lu; Ma, Qilin; Liu, Chen; Chen, Xiaoping; Li, Hanping; Lai, Weihua; Zhong, Shilong*Frontiers in Molecular Biosciences, 2021, 8: 632950.被引 14
- Plasma metabolomics provides new insights into the relationship between metabolites and outcomes and left ventricular remodeling of coronary artery diseaseZhu, Qian; Qin, Min; Wang, Zixian; Wu, Yonglin; Chen, Xiaoping; Liu, Chen; Ma, Qilin; Liu, Yibin; Lai, Weihua; Chen, Hui; Cai, Jingjing; Liu, Yemao; Lei, Fang; Zhang, Bin; Zhang, Shuyao; He, Guodong; Li, Hanping; Zhang, Mingliang; Zheng, Hui; Chen, Jiyan; Huang, Min; Zhong, Shilong*Cell and Bioscience, 2022, 12(1): 173.被引 3
